Anticancer agent-367
Anticancer agent-367 is a 3-hydroxy-3′,4′,5′-trimethoxyflavone derivative with selective cytotoxicity against osteosarcoma cells (IC50 = 14 μM). Anticancer agent-367 reduces AKT phosphorylation levels in 143B osteosarcoma cells and downregulates the expression of epithelial-mesenchymal transition-related genes such as ZEB1, MMP2, and MMP9. The combination of Anticancer agent-367 with Doxorubicin (HY-15142A) produces a synergistic antiproliferative effect on 143B cells. Anticancer agent-367 can be used in osteosarcoma-related research.
For research use only. We do not sell to patients.
- Formula: C23H25NO6
- Molecular Weight:411.45
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
Akt |
MMP-9 |
MMP-2 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| 143B | IC50 |
14 μM
|
Cytotoxicity against human 143B osteosarcoma cells assessed as viability reduction after 48 hrs by WST-8/CCK-8 assay.
Cytotoxicity against human 143B osteosarcoma cells assessed as viability reduction after 48 hrs by WST-8/CCK-8 assay.
|
42664600 |
| 143B | IC50 |
2.0 μM
|
Antiproliferative activity against human 143B osteosarcoma cells assessed as growth inhibition after 48 hrs by SRB assay.
Antiproliferative activity against human 143B osteosarcoma cells assessed as growth inhibition after 48 hrs by SRB assay.
|
42664600 |
In Vitro
Anticancer agent-367 (compound 6A) (0-160 μmol/L) inhibits 143B osteosarcoma cell viability and growth, with a WST-8 IC50 of 14 μmol/L and an SRB IC50 of 2.0 μmol/L; it exhibits low toxicity toward MRC-5 lung fibroblasts[1].
Anticancer agent-367 (0-56 μmol/L) produced a synergistic effect with doxorubicin in 143B osteosarcoma cells, with CI = 0.9272 and DRI >1, supporting a reduction in the doxorubicin dose[1].
Anticancer agent-367 (7-14 μmol/L; 48 h) reduces p-AKT in 143B osteosarcoma cells at 14 μmol/L alone or in combination with doxorubicin[1].
Anticancer agent-367 (7-14 μmol/L; 48 h) downregulates the EMT-related genes ZEB1, MMP2, and MMP9 in 143B osteosarcoma cells, and further downregulates MMP9[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:143B human osteosarcoma cells, MRC-5 human fetal lung fibroblasts
-
Concentration:0, 10, 20, 40, 80, 160 μmol/L
-
Incubation Time:48 h
-
Result:Produced dose-dependent inhibition of 143B cell viability and growth.
Showed low toxicity toward MRC-5 cells.
At 80 μmol/L, resulted in 5% inhibition of cell viability.
Displayed lower cytotoxicity than 6b at higher concentrations (>80 μmol/L).
Below 40 μmol/L, did not reduce MRC-5 cell viability.
-
Cell Line:143B human osteosarcoma cells
-
Concentration:7 and 14 μmol/L
0.075 and 0.15 μmol/L Doxorubicin -
Incubation Time:48 h
-
Result:Reduced p‑AKT levels showed no significant change when compound 6a was applied as a single agent at 7 μmol/L.
Reduced p‑AKT levels significantly when 7 μmol/L compound 6a was combined with Doxorubicin.
Reduced p‑AKT expression markedly at 14 μmol/L regardless of monotherapy or Doxorubicin combination, which indicated the inhibition of AKT signaling.
-
Cell Line:143B human osteosarcoma cells
-
Concentration:7 and 14 μmol/L
0.075 and 0.15 μmol/L Doxorubicin -
Incubation Time:48 h
-
Result:Downregulated ZEB1, MMP2, and MMP9 in a concentration‑dependent manner when used as a single agent.
Exhibited similar down‑regulation trends for MMP2 and MMP9 expression under combination with doxorubicin, yet produced no significant influence on ZEB1 levels.
Exerted additional suppressive effect on MMP9 expression.
Chemical Information
-
Molecular Weight 411.45
-
Formula C23H25NO6
-
SMILES
O=C1C2=CC=C(N3CCCCC3)C=C2OC(C4=CC(OC)=C(OC)C(OC)=C4)=C1O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)